Koru Medical Systems (NSDQ:KRMD) today announced that it has appointed Linda Tharby as president and CEO, effective April 12.
Tharby will succeed interim CEO Jim Beck, who will continue to serve on the company’s board of directors.
“On behalf of the board of directors and our entire company, I’d like to thank Jim for stepping up to lead the company through this process. I am very pleased to welcome Linda to the Koru Medical team,” chairperson of the board John Fletcher said in a news release. “Linda brings to Koru a successful track record of relevant executive experience, building and leading strong performing global organizations, developing and commercializing multiple product and service innovations and delivering solutions to patients in the home setting. The board is confident that under Linda’s direction, Koru Medical is well-positioned for our next phase of growth as we continue to focus on improving the quality of life of home infusion patients around the world.”
Prior to joining the company, Tharby most recently served as chief customer experience officer at BD. She also held numerous leadership roles at BD, including executive VP and president of life sciences, group president of preanalytical systems at BD Biosciences, worldwide president of diabetes care, VP/GM of pharmaceutical systems and chief human resources officer.
“I am honored and excited to have the opportunity to join the Company at a pivotal moment in its development,” Tharby said. “Koru Medical addresses a growing patient preference and a global shift to increased healthcare delivery in the home. Koru Medical’s products and services deliver life-saving treatments to patients and provide them the freedom to infuse where and why they choose. I look forward to working with our employees, the executive management team and the board in our mission to improve the quality of life for patients around the world and to deliver meaningful value to our patients, customers and shareholders.”